Covalon Technologies Ltd - ESG Rating & Company Profile powered by AI
Detailed Sustainability assessment of Covalon Technologies Ltd can be accessed by logging in. This assessment of Covalon Technologies Ltd incorporates data points from across the web and also from available documents by Covalon Technologies Ltd. This page is a zero-cost Environmental, Social and Governance assessment for Covalon Technologies Ltd.
Covalon Technologies Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Covalon Technologies Ltd | 8.0 | High |
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Covalon Technologies Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Covalon Technologies Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Covalon Technologies Ltd report the average age of the workforce?
Sign up for free to unlockDoes Covalon Technologies Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Covalon Technologies Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Covalon Technologies Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Covalon Technologies Ltd offer flexible work?
Sign up for free to unlockDoes Covalon Technologies Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Covalon Technologies Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Covalon Technologies Ltd conduct supply chain audits?
Sign up for free to unlockDoes Covalon Technologies Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Covalon Technologies Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Covalon Technologies Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Covalon Technologies Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Covalon Technologies Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Covalon Technologies Ltd disclose water use targets?
Sign up for free to unlockDoes Covalon Technologies Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Covalon Technologies Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Covalon Technologies Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Covalon Technologies Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Covalon Technologies Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Covalon Technologies Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Covalon Technologies Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Covalon Technologies Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Covalon Technologies Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Covalon Technologies Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Covalon Technologies Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Covalon Technologies Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Covalon Technologies Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Covalon Technologies Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Covalon Technologies Ltd disclose its waste policy?
Sign up for free to unlockDoes Covalon Technologies Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Covalon Technologies Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Covalon Technologies Ltd disclose energy use targets?
Sign up for free to unlockDoes Covalon Technologies Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Covalon Technologies Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Covalon Technologies Ltd
These potential risks are based on the size, segment and geographies of the company.
Covalon Technologies Ltd. researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, Europe, the Middle East, Asia, Latin America, and internationally. The company has 3 proprietary platform technologies, including collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; antimicrobial silicone adhesive platform that is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity; and medical coating platform, a proprietary process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device. Its products include wound care dressings; surgical and peri-operative products; and infection management products. The company offers its products under the Covalon brand name through third-party distribution networks and company's direct sales force. It serves hospitals, wound care centers, burn centers, extended/alternate care and acute care facilities, home health care agencies, and physicians' offices. The company is headquartered in Mississauga, Canada.